adenosine and squalene
adenosine has been researched along with squalene in 7 studies
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors
Authors | Studies |
---|---|
Ducruet, AF; Faraji, AH; Weiner, GM | 1 |
Andrieux, K; Chacun, H; Clayette, P; Courbebaisse, Y; Couvreur, P; Desmaële, D; Garcia-Argote, S; Gaudin, A; Goncalves, J; Lepetre-Mouelhi, S; Loreau, O; Mougin, J; Parrod, M; Pieters, G; Rousseau, B | 1 |
Amenitsch, H; Bourgaux, C; Couvreur, P; Desmaële, D; Lepeltier, E; Lepetre-Mouelhi, S; Rosilio, V; Zouhiri, F | 1 |
Couvreur, P; Dufrançais, O; Garcia-Argote, S; IJzerman, AP; Lepetre-Mouelhi, S; Mougin, J; Pieters, G; Rouquette, M; Yang, X | 1 |
Brusini, R; Calet, S; Couvreur, P; Desmaële, D; Dormont, F; Gobeaux, F; Lepetre-Mouelhi, S; Mahatsekake, C; Peramo, A; Rouquette, M; Testard, F; Varna, M | 1 |
Bizeau, J; Couvreur, P; Desmaële, D; Gobeaux, F; Grillo, I; Guenoun, P; Lepêtre-Mouelhi, S; Marichal, L; Ramseyer, C; Renault, JP; Rouquette, M; Samson, F; Testard, F; Wien, F; Yesylevsky, SO | 1 |
Brusini, R; Cailleau, C; Couvreur, P; Dormont, F; Gaudin, F; Gendron, A; Mougin, J; Peramo, A; Reynaud, F; Varna, M | 1 |
Other Studies
7 other study(ies) available for adenosine and squalene
Article | Year |
---|---|
The use of nanotechnology to improve the neuroprotective effects of adenosine in stroke and spinal cord injury.
Topics: Adenosine; Animals; Drug Delivery Systems; Humans; Male; Nanoparticles; Nanotechnology; Neuroprotective Agents; Spinal Cord Injuries; Squalene; Stroke | 2015 |
Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis.
Topics: Adenosine; Animals; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Male; Mice; Nanoparticles; Prodrugs; Squalene; Tissue Distribution; Tritium | 2015 |
Influence of the nanoprecipitation conditions on the supramolecular structure of squalenoyled nanoparticles.
Topics: Adenosine; Chemical Precipitation; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Design; Ethanol; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Nanoparticles; Neuroprotective Agents; Particle Size; Solutions; Solvents; Squalene; Water | 2015 |
Squalene-Adenosine Nanoparticles: Ligands of Adenosine Receptors or Adenosine Prodrug?
Topics: Adenosine; Animals; Biological Transport; CHO Cells; Cricetulus; Extracellular Space; HEK293 Cells; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Ligands; Nanoparticles; Prodrugs; Receptors, Purinergic P1; Squalene | 2019 |
Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles.
Topics: Adenosine; Adsorption; Animals; Blood Proteins; Cell Line; Cell Survival; Male; Mice; Nanomedicine; Nanoparticles; Rats, Sprague-Dawley; Squalene | 2019 |
Albumin-driven disassembly of lipidic nanoparticles: the specific case of the squalene-adenosine nanodrug.
Topics: Adenosine; Animals; Binding Sites; Colloids; Drug Stability; Humans; Mice; Nanoparticles; Prodrugs; Protein Binding; Serum Albumin; Squalene | 2020 |
Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents.
Topics: Adenosine; alpha-Tocopherol; Animals; Antioxidants; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Drug Delivery Systems; Endotoxemia; Female; Immunologic Factors; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Squalene; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2020 |